Protein-O-methyltransferase in brain synaptosomal fraction under normal, ischemic and hypoxic conditions. Possible

Insights

Protein-O-methyltransferase activity in brain synaptosomes decreases under hypoxia and ischemia. Changes in methyl acceptor proteins may explain altered neurotransmitter uptake, affecting GABA and dopamine levels.

Area of Science:

  • Neurochemistry
  • Enzymology
  • Cellular Neuroscience

Background:

  • Protein-O-methyltransferase (POMT) plays a role in post-translational modifications.
  • Synaptosomes are crucial for studying neurotransmitter transport and neuronal function.

Purpose of the Study:

  • To investigate the activity of POMT in synaptosomal fractions under normal, hypoxic, and ischemic conditions.
  • To explore the impact of POMT activity on neurotransmitter uptake.

Main Methods:

  • Enzyme kinetics were used to determine Km and Vmax for S-adenosylmethionine.
  • Synaptosomal fractions were subjected to hypoxic and ischemic conditions.
  • Neurotransmitter uptake assays (GABA, dopamine, serotonin, noradrenaline) were performed.

Main Results:

  • POMT activity showed a Km of 1 µM for S-adenosylmethionine and Vmax of 4.3 pmoles/mg protein/min.
  • Activity was significantly higher with an exogenous protein acceptor (gelatin).
  • Endogenous POMT activity decreased by ~20% in hypoxia and ~15% in ischemia, while exogenous activity remained unchanged.
  • Inhibition of methylcarboxylation led to decreased GABA uptake and increased dopamine uptake.

Conclusions:

  • Hypoxia and ischemia reduce endogenous POMT activity in synaptosomes.
  • Altered methyl acceptor proteins likely contribute to changes in neurotransmitter uptake under these conditions.
  • POMT activity modulation may impact neuronal signaling pathways.

Related Concept Videos